SequenceBase Corporation announces the launch of the USGENE® BLAST® Search Portal / All sequences from the published applications and issued patents of the United States Patent & Trademark Office (USPTO), are now available via a new web-based service called the USGENE BLAST Search Portal / Limited time offer of completely free-of-charge access for 30 days

Edison, NJ, USA, March 6, 2012 – SequenceBase Corporation is pleased to announce the release of the USGENE BLAST Search Portal. The USGENE database is an invaluable resource for freedom-to-operate, prior-art, validity and patent infringement searches, and, for the first time, is now available via an all-new web-based USGENE BLAST Search Portal service.

The USGENE BLAST Search Portal offers the entire USGENE database at a predictable fixed price on either a per-project or annual subscription basis. For a limited time only, unrestricted subscription access to this new service is available completely free-of-charge for 30 days.

The USPTO Genetic Sequence Database, USGENE, was launched in 2007, and covers all available protein and nucleic acid sequences from the published applications and issued patents of the United States Patent & Trademark Office (USPTO), from 1981 to date. The database remains the unparalleled resource for U.S. freedom-to-operate, prior-art, validity and infringement patent sequence searches.

The features of the new USGENE BLAST Search Portal include an easy-to-use, project-oriented work-flow, automatic BLAST settings adjustment for short queries, and the capability of multiple sequence upload. The service also provides seamless links to Espacenet and USPTO original documents, USPTO (re-)assignment data, and organism details in the NCBI Taxonomy database.

The USGENE BLAST Search Portal database incorporates a definitive version of USGENE, with a complete collection of sequence data from “mega” documents, and, for the first time, day of publication updating – Tuesday for granted patents and Thursday for published applications. In addition, a complete bibliographic back file is included, with priority details, patent sequence location, and organism name standardization all available back to the beginning of the database.

The USGENE BLAST Search Portal provides a streamlined, easy-to-use U.S. sequence patent sequence search platform that even novice sequence searchers will find valuable.

“The USGENE BLAST Search Portal provides a unique new access point to explore the biological data – sequences, organism names, molecule types, sequence ID numbers and feature tables – from within original USPTO data,” commented Martin Goffman, President and CEO, SequenceBase Corporation. “We are delighted to be able to provide this entirely new way to perform U.S. freedom-to-operate, prior-art, validity and infringement patent sequence searches, via a simplified, modern, web-based interface.”

“The unique combination of USGENE content, with a modern, project-oriented, Basic Local Alignment Search Tool (BLAST) based interface, gives life-science intellectual property professionals the ability to make business critical decisions with greater certainty than was possible before,” added Martin Goffman, “and I join my colleagues and peers throughout the patent information industry in welcoming its arrival with great enthusiasm.”

The USGENE BLAST Search Portal provides a streamlined, easy-to-use U.S. sequence patent sequence search platform that even novice sequence searchers will find valuable.

 

The USGENE BLAST Search Portal is available now at usgene.sequencebase.com.

 

About the SequenceBase Corporation

The SequenceBase Corporation is a leader in providing patent sequence information to the legal, biotech, pharmaceutical, scientific, technical, and academic community. In addition to being the producer of USGENE® on STN®, and providing the USGENE BLAST Search Portal, SequenceBase Corporation supplies customized subscription download services of patent sequence information, to a wide variety of clients. SequenceBase Corporation pools sequence information from various world-wide resources, standardizes its collection and then supplies it in multiple standard formats to suit individual in-house patent bioinformatics information needs. For further information on our products and services, please contact us either via http://www.sequencebase.com/contact-sequencebase-patents , or by email at techsupport@sequencebase.com

PDF version

For further information, please contact:

Martin Goffman
President and CEO
SequenceBase Corporation
Tel: +1 732 549-5433
E-Mail: techsupport@sequencebase.com
sequencebase.com